Report cover image

Non-melanoma Skin Cancer Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Oct 21, 2024
Length 126 Pages
SKU # PROD19315085

Description

Non-melanoma Skin Cancer Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape


The global non-melanoma skin cancer treatment market is expected to grow at a CAGR of around 8.2% during 2025-2034. This report on global non-melanoma skin cancer treatment market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global non-melanoma skin cancer treatment market by segmenting the market based on treatment type, indication, end use, and region. Also, detailed profiles of companies operating in the non-melanoma skin cancer treatment market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Cases of Skin Cancer
• Rising Adoption of Immunotherapy
• Drug Approvals

Market Challenges

• Side Effects due to Treatment

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Treatment Type

• Chemotherapy
• Radiation Therapy
• Photodynamic Therapy
• Others

Market by Indication

• Basal Cell Carcinoma
• T-Cell Lymphoma
• Squamous Cell Carcinoma
• Others

Market by End Use

• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers
• Others

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

126 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Non-melanoma Skin Cancer Treatment Market
3.1. Introduction
3.2. Market Drives
3.3. Market Challenges
4. Global Non-melanoma Skin Cancer Treatment Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Non-melanoma Skin Cancer Treatment Market by Treatment Type
5.1. Introduction
5.2. Chemotherapy
5.3. Radiation Therapy
5.4. Photodynamic Therapy
5.5. Others
6. Global Non-melanoma Skin Cancer Treatment Market by Indication
6.1. Introduction
6.2. Basal Cell Carcinoma
6.3. T-Cell Lymphoma
6.4. Squamous Cell Carcinoma
6.5. Others
7. Global Non-melanoma Skin Cancer Treatment Market by End Use
7.1. Introduction
7.2. Hospitals
7.3. Specialty Clinics
7.4. Ambulatory Surgery Centers
7.5. Others
8. Global Non-melanoma Skin Cancer Treatment Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Almirall S.A.
12.2.2. Amgen Inc.
12.2.3. Boehringer Ingelheim GmbH
12.2.4. Bristol-Myers Squibb Company
12.2.5. Elekta AB
12.2.6. Eli Lilly and Company
12.2.7. F. Hoffmann-La Roche AG
12.2.8. GlaxoSmithKline Plc
12.2.9. Icad Inc.
12.2.10. Merck & Co. Inc.
12.2.11. Novartis AG
12.2.12. Pfizer
12.2.13. Regeneron Pharmaceuticals, Inc.
12.2.14. Sun Pharmaceutical Industries Limited
12.2.15. Varian Medical Systems Inc.
List of Figures
Figure 1: Global Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 2: Global Non-melanoma Skin Cancer Treatment Market by Treatment Type, 2024
Figure 3: Global Non-melanoma Skin Cancer Treatment Market by Indication, 2024
Figure 4: Global Non-melanoma Skin Cancer Treatment Market by End Use, 2024
Figure 5: Global Non-melanoma Skin Cancer Treatment Market by Region, 2024
Figure 6: Global Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 7: Global Non-melanoma Skin Cancer Treatment Market by Product (in %), 2024 & 2034
Figure 8: Global Non-melanoma Skin Cancer Chemotherapy Market (in US$ Million), 2020-2024
Figure 9: Global Non-melanoma Skin Cancer Chemotherapy Market (in US$ Million), 2025-2034
Figure 10: Global Non-melanoma Skin Cancer Radiation Therapy Market (in US$ Million), 2020-2024
Figure 11: Global Non-melanoma Skin Cancer Radiation Therapy Market (in US$ Million), 2025-2034
Figure 12: Global Non-melanoma Skin Cancer Photodynamic Therapy Market (in US$ Million), 2020-2024
Figure 13: Global Non-melanoma Skin Cancer Photodynamic Therapy Market (in US$ Million), 2025-2034
Figure 14: Global Non-melanoma Skin Cancer Other Therapies Market (in US$ Million), 2020-2024
Figure 15: Global Non-melanoma Skin Cancer Other Therapies Market (in US$ Million), 2025-2034
Figure 16: Global Non-melanoma Skin Cancer Treatment Market by Indication (in %), 2024 & 2034
Figure 17: Global Basal Cell Carcinoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 18: Global Basal Cell Carcinoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 19: Global T-Cell Lymphoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 20: Global T-Cell Lymphoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 21: Global Squamous Cell Carcinoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 22: Global Squamous Cell Carcinoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 23: Global Other Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 24: Global Other Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 25: Global Non-melanoma Skin Cancer Treatment Market by End Use (in %), 2024 & 2034
Figure 26: Global Hospitals Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 27: Global Hospitals Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 28: Global Specialty Clinics Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 29: Global Specialty Clinics Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 30: Global ASCs Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 31: Global ASCs Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 32: Global Other Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 33: Global Other Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 34: Global Non-melanoma Skin Cancer Treatment Market by Region (in %), 2024 & 2034
Figure 35: Europe Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 36: Europe Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 37: Europe Non-melanoma Skin Cancer Treatment Market by Country (in %), 2024 & 2034
Figure 38: Germany Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 39: United Kingdom Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 40: France Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 41: Italy Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 42: Spain Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 43: Russia Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 44: Netherlands Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 45: Rest of Europe Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 46: North America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 47: North America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 48: North America Non-melanoma Skin Cancer Treatment Market by Country (in %), 2024 & 2034
Figure 49: United States Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 50: Canada Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 51: Asia Pacific Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 52: Asia Pacific Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 53: Asia Pacific Non-melanoma Skin Cancer Treatment Market by Country (in %), 2024 & 2034
Figure 54: China Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 55: Japan Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 56: India Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 57: South Korea Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 58: Australia Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 59: Indonesia Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 60: Rest of Asia Pacific Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 61: Latin America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 62: Latin America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 63: Latin America Non-melanoma Skin Cancer Treatment Market by Country (in %), 2024 & 2034
Figure 64: Mexico Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 65: Brazil Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 66: Argentina Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 67: Rest of Latin America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 68: Middle East & Africa Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2024
Figure 69: Middle East & Africa Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2025-2034
Figure 70: Middle East & Africa Non-melanoma Skin Cancer Treatment Market by Country (in %), 2024 & 2034
Figure 71: Saudi Arabia Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 72: Turkey Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 73: Iran Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 74: UAE Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 75: Rest of Middle East and Africa Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2020-2034
Figure 76: Market Value Chain
List of Tables
Table 1: Global Non-melanoma Skin Cancer Treatment Market Portraiture
Table 2: Global Non-melanoma Skin Cancer Treatment Market by Treatment Type (in US$ Million), 2024 & 2034
Table 3: Global Non-melanoma Skin Cancer Treatment Market by Indication (in US$ Million), 2024 & 2034
Table 4: Global Non-melanoma Skin Cancer Treatment Market by End Use (in US$ Million), 2024 & 2034
Table 5: Global Non-melanoma Skin Cancer Treatment Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2024 & 2034
Table 11: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us